NASDAQ:HBIO

Harvard Bioscience: HBIO stock stalls, margin pressure in focus
····

Harvard Bioscience: HBIO stock stalls, margin pressure in focus

Harvard Bioscience closed at $5.59 Friday, up 1.3% for the day and 6.5% for the week, following a 1-for-10 reverse stock split in March. First-quarter revenue fell to $20.8 million, with a net loss of $3.4 million and gross margin rising to 59%. The company cited weak demand from academic and distributor customers and faces a 17.3% effective interest rate on borrowings. CEO John Duke and CFO Mark Frost will speak at a virtual conference May 28.
May 25, 2026

Stock Market Today

  • US Consumer Stocks Slide Amid Inflation Concerns and Growing Debt
    June 1, 2026, 10:12 PM EDT. Walmart shares fell 14% in two weeks, and Costco dropped 13% since May 19, signaling potential decline in consumer spending, critical for the economy. Analysts warn that inflation, driven by expansive federal spending-dubbed the "Funny Money" system where increasing money supply reduces dollar value-continues to pressure markets. US government debt has doubled from $20 trillion in 2016 to nearly $40 trillion, raising concerns over fiscal sustainability. This expansion benefits early money recipients (Cantillon Effect) while harming latecomers. The aging Boomer generation defends the current economic status, but younger voters face a deteriorating financial landscape. Market watchers view these retail stock declines as key indicators of potential broader economic weakness.